netFormulary NHS
North East and North Cumbria
ICS Formulary

Looking for Apremilast found 7 matches

Open monograph to display formulary status BNF Category
  Apremilast  (Otezla®) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Apremilast  (Otezla®) Skin - Drugs affecting the immune response - 13.05.03

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Jan 2017): Apremilast (Otezla ▼): risk of suicidal thoughts and behaviour (10.01.03)
link in drug section MHRA Drug Safety Update (Jan 2017): Apremilast (Otezla ): risk of suicidal thoughts and behaviour (13.05.03)
link in drug section NICE TA419: Apremilast for treating moderate to severe plaque psoriasis (13.05.03)
link in drug section NICE TA433: Apremilast for treating active psoriatic arthritis (10.01.03)
link in drug section NICE TA433: Apremilast for treating active psoriatic arthritis (13.05.03)